Hueck lidding foils solves blister problem
Hueck Folien, one of the largest European foil converters in the flexible packaging sector, has introduced an aluminium lidding foil which is sealable against Aclar, a widely used material in blister films.
Archives for October 17, 2004
FDA clears RFID chip for humans
The US Food and Drug Administration this week approved the first implantable radiofrequency identification microchip for human use, elevating RFID from a tool for supply chain management into an enabling technology for improving healthcare delivery to...
Belgium's Peakadilly set up to exploit 'pharmacoproteomics'
A new biotechnology company - Peakadilly - has been set up in Belgium to provide molecular diagnostic tools to guide the development of new drugs. The company maintains that the tools will make drug development more efficient, effective and...
Positive steps forward in malaria prevention
Children around the world at risk of malaria took a step closer to having a protective vaccine with the reporting of encouraging new data on a candidate developed by GlaxoSmithKline Biologicals.
Spanish pharma firm ramps up capacity
Spanish pharmaceutical company Lacer has unveiled a new investment programme at a plant in Barcelona that will dramatically increase its production capacity.
Applied Bio system speeds PCR
Applied Biosystems has launched a new system for carrying out polymerase chain reaction (PCR) experiments in 96-well plates that can dramatically cut the time it takes to carry out the procedure.
BMJ report seeks side effect disclosure
Researchers writing in the British Medical Journal have argued that drug companies must disclose all adverse events encountered during drug development ahead of licensing.
Rexam chief canned after 5 months
Rexam, which makes pharmaceutical packaging and is also the world's largest manufacturer of aluminium cans, has sacked chief executive Stefan Angwald after just five months on the job.
Biomanufacturing key to cutting costs
Cost reductions associated with advances in large-scale biopharmaceutical manufacturing will play a role in reducing healthcare costs, according to a new publication.
Drug target for muscle wasting emerges
Research into the causes of muscle wasting in diseases such as cancer and diabetes have thrown up a new potential drug target, according to US researchers, who report their findings in Cell (15 October issue).